Evidence map›Paper›PMID 34457090›Full record

ArticleDisease markers2021

High mRNA Expression of

Zhongyuan Cui, Lijia Xiao, Fengsui Chen, Jielong Wang, Haiyan Lin, Dongliang Li, Zhixian Wu

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mitosis-related geneAnnals of translational medicine · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zhongyuan CuiDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.ORCID https://orcid.org/0000-0001-9476-9870
Lijia XiaoDepartment of Disease Prevention and Control, General Hospital of Western Theater Command, Chengdu, Sichuan 610000, China.
Fengsui ChenDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
Jielong WangDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
Haiyan LinDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Fujian Medical University, Fuzhou, Fujian 350025, China.
Dongliang LiDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.ORCID https://orcid.org/0000-0001-5536-8468
Zhixian WuDepartment of Hepatobiliary Disease, 900th Hospital of the Joint Logistics Support Force, Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.ORCID https://orcid.org/0000-0002-0708-6770
Fujian Medical University · CNXiamen University · CNSichuan Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centromere proteins (CENPs) are the main constituent proteins of kinetochore, which are essential for cell division. In recent years, several studies have revealed that several CENPs were aberrantly expressed in hepatocellular carcinoma (HCC). However, numerous centromere proteins have not been studied in HCC. In this study, we used databases of Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), the Kaplan-Meier Plotter, cBioPortal, the Human Protein Atlas (HPA), and TIMER (Tumor Immune Estimation Resource) and immunohistochemical staining of clinical specimens to investigate the expression of 15 major centromere proteins in HCC to evaluate their potential prognostic value. We found that the mRNA levels of 4 out of 15 centromere proteins (CENPL, CENPQ, CENPR, and CENPU) were significantly higher in HCC than in normal tissues, and their mRNA levels were associated with the tumor stages (

Indexed as

Gene Expression Regulation, NeoplasticBiomarkers, TumorCarcinoma, HepatocellularCase-Control StudiesCell Cycle ProteinsChromosomal Proteins, Non-HistoneFemaleFollow-Up StudiesGene Expression ProfilingHumansLiver NeoplasmsLymphocytes, Tumor-InfiltratingMaleNeoplasm Recurrence, LocalPrognosisRNA, MessengerBiomarkers, TumorCell Cycle ProteinsCENPL protein, humanChromosomal Proteins, Non-HistoneRNA, Messenger

Identifiers

PMID34457090
PMCPMC8387183
OpenAlexW3193285454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.